Low DNA repair is a risk factor in skin carcinogenesis: A study of basal cell carcinoma in psoriasis patients

Mutation Research - DNA Repair

Volumn 433, Issue 1, 1999, Pages 15-22

  Dybdahl, Marianne ^a   Frentz, Gerda ^b   Vogel, Ulla ^a   Wallin, Håkan ^a   Nexø, Bjørn A ^a  

^a NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^b Department of Rheumatology and the Osteoporosis Research Centre   (Denmark)

Author keywords

Chemical carcinogenesis; Host cell reactivation; Nucleotide excision repair; Psoralen; Skin cancer; UV radiation

Indexed keywords

METHOTREXATE; PSORALEN; TAR;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; EXCISION REPAIR; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; SKIN CANCER; SKIN CARCINOGENESIS; ULTRAVIOLET A RADIATION;

ADULT; AGE FACTORS; CARCINOMA, BASAL CELL; DENMARK; DNA REPAIR; DNA, NEOPLASM; FEMALE; FICUSIN; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; PSORIASIS; RISK FACTORS; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC; TRANSFECTION; TUMOR CELLS, CULTURED; ULTRAVIOLET THERAPY;

EID: 0032969571     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(98)00057-3     Document Type: Article

References (14)

1. Kraemer K.H., Lee M.M., Scotto J. Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch. Dermatol. 123:1987;241-250.
2. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc. Natl. Acad. Sci. USA. 90:1993;1614-1618.
3. Wei Q., Cheng L., Hong W.K., Spitz M.R. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 56:1996;4103-4107.
4. Olsen J.H., Møller H., Frentz G. Malignant tumors in patients with psoriasis. J. Am. Acad. Dermatol. 27:1992;716-722.
5. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning. A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press, New York, 1989.
6. Cheng L., Bucana C.D., Wei Q. Fluorescence in situ hybridization method for measuring transfection efficiency. Biotechniques. 21:1996;486-491.
7. Athas W.F., Hedayati M.A., Matanoski G.M., Farmer E.R., Grossman L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res. 51:1991;5786-5793.
8. Protic-Sabljic M., Kraemer K.H. One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells. Proc. Natl. Acad. Sci. USA. 82:1985;6622-6626.
9. Stern R.S., Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer. 73:1994;2759-2764.
10. E.C. Friedberg, G.C. Walker, W. Siede, DNA Repair and Mutagenesis, American Society for Microbiology, Washington, 1995.
11. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair related to multiple skin cancers and drug use. Cancer Res. 54:1994;437-440.
12. Munch-Petersen B., Frentz G., Squire B., Wallevik K., Horn C.C., Reymann F., Faber M. Abnormal lymphocyte response to UV radiation in multiple skin cancer. Carcinogenesis. 6:1985;843-845.
13. Møller P., Knudsen L.E., Frentz G., Dybdahl M., Wallin H., Nexø B.A. Seasonal variation of DNA damage and repair in patients with non-melanoma skin cancer and referents with and without psoriasis. Mutat. Res. 407:1998;25-34.
14. Karagas M.R., Greenberg E.R., Mott L.A., Baron J.A., Ernster V.L. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol. Biomarkers Prev. 7:1998;157-161.